Stock KRON KRONOS BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Kronos Bio, Inc.

Equities

KRON

US50107A1043

Real-time Estimate Cboe BZX
Other stock markets
 11:12:23 2024-06-20 EDT 		5-day change 1st Jan Change
1.065 USD +5.45% Intraday chart for Kronos Bio, Inc. 0.00% -15.20%
05-23 Kronos Bio, Inc. to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology Annual Meeting CI
05-21 Kronos Bio, Inc. Announces Executive Changes CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
GL
Kronos Bio to Participate in Three Upcoming Healthcare Conferences and Events
GL
Kronos Bio Appoints Deborah Knobelman, Ph.D. as Chief Operating Officer and Chief Financial Officer 
GL
Kronos Bio Reports First-Quarter 2024 Financial Results
GL
Kronos Bio Reports First-Quarter 2024 Financial Results
AQ
Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
GL
Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2023 Financial Results
GL
Kronos Bio Announces Restructuring to Focus Resources on Clinical Development with Extended Cash Runway
GL
Kronos Bio To Present Three Posters at AACR 2024 Annual Meeting
GL
Kronos Bio Announces Participation in 44th Annual Cowen Health Care Conference
GL
Kronos Bio Announces Participation in 44th Annual Cowen Health Care Conference
AQ
Kronos Bio Implements New Leadership Structure to Drive Pipeline Advancement
GL
Kronos Bio Implements New Leadership Structure to Drive Pipeline Advancement
AQ
Kronos Bio Announces Pipeline Update and p300 KAT Inhibitor Development Candidate
GL
Kronos Bio Announces Participation in H.C. Wainwright 4th Annual Precision Oncology Virtual Conference
GL
Kronos Bio Announces Participation in H.C. Wainwright 4th Annual Precision Oncology Virtual Conference
AQ
Kronos Bio Announces Participation in 35th Annual Piper Sandler Healthcare Conference
GL
Kronos Bio Announces Participation in 35th Annual Piper Sandler Healthcare Conference
AQ
Kronos Bio Reports Recent Business Progress and Third-Quarter 2023 Financial Results
GL
Kronos Bio Announces Plan to Optimize Resource Allocation, Restructure and Contain Costs Following Positive Preliminary Clinical Data from its KB-0742 Phase 1/2 Study
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KRON Stock
  4. News Kronos Bio, Inc.
  5. Press Releases